Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 2,033

The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.

New photosensitizers for photodynamic therapy

Open access
Abrahamse, Heidi, Hamblin, Michael R. · 2016 · Biochemical Journal

Abstract

Photodynamic therapy (PDT) was discovered more than 100 years ago, and has since become a well-studied therapy for cancer and various non-malignant diseases including infections. PDT uses photosensitizers (PSs, non-toxic dyes) that are activated by absorption of visible light to initially form the excited singlet state, followed by transition to the long-lived excited triplet state. This triplet state can undergo photochemical reactions in the presence of oxygen to form reactive oxygen species (including singlet oxygen) that can destroy cancer cells, pathogenic microbes and unwanted tissue. The dual-specificity of PDT relies on accumulation of the PS in diseased tissue and also on localized light delivery. Tetrapyrrole structures such as porphyrins, chlorins, bacteriochlorins and phthalocyanines with appropriate functionalization have been widely investigated in PDT, and several compounds have received clinical approval. Other molecular structures including the synthetic dyes classes as phenothiazinium, squaraine and BODIPY (boron-dipyrromethene), transition metal complexes, and natural products such as hypericin, riboflavin and curcumin have been investigated. Targeted PDT uses PSs conjugated to antibodies, peptides, proteins and other ligands with specific cellular receptors. Nanotechnology has made a significant contribution to PDT, giving rise to approaches such as nanoparticle delivery, fullerene-based PSs, titania photocatalysis, and the use of upconverting nanoparticles to increase light penetration into tissue. Future directions include photochemical internalization, genetically encoded protein PSs, theranostics, two-photon absorption PDT, and sonodynamic therapy using ultrasound.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20150942

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Chan, 2010, Verteporfin PDT for non-standard indications—a review of current literature, Graefes Arch. Clin. Exp. Ophthalmol., 248, 613, 10.1007/s00417-010-1307-z · doi:10.1007/s00417-010-1307-z
  2. Romanko, 2004, Effect of photodynamic therapy with photodithazine on morphofunctional parameters of M-1 sarcoma, Bull. Exp. Biol. Med., 138, 584, 10.1007/s10517-005-0133-5 · doi:10.1007/s10517-005-0133-5
  3. Chin, 2006, The potential application of chlorin e6-polyvinylpyrrolidone formulation in photodynamic therapy, Photochem. Photobiol. Sci., 5, 1031, 10.1039/b605772a · DOI
  4. Nanashima, 2015, Current status of photodynamic therapy in digestive tract carcinoma in Japan, Int. J. Mol. Sci., 16, 3434, 10.3390/ijms16023434 · doi:10.3390/ijms16023434
  5. Saavedra, 2014, Modulation of biodistribution, pharmacokinetics, and photosensitivity with the delivery vehicle of a bacteriochlorin photosensitizer for photodynamic therapy, ChemMedChem, 9, 390, 10.1002/cmdc.201300449 · DOI
  6. Schieweck, 1994, CGP 55847, liposome-delivered zinc(II) phthalocyanine as phototherapeutic agent for tumours, Proc. SPIE, 2078, 2078
  7. Mannucci, 2014, Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study—the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study, Acta Diabetol., 51, 435, 10.1007/s00592-013-0533-3 · doi:10.1007/s00592-013-0533-3
  8. Graciano, 2015, Using chitosan gels as a toluidine blue O delivery system for photodynamic therapy of buccal cancer: in vitro and in vivo studies, Photodiagnosis Photodyn. Ther., 12, 98, 10.1016/j.pdpdt.2014.11.003 · doi:10.1016/j.pdpdt.2014.11.003
  9. Frimberger, 1998, Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer, Clin. Cancer Res., 4, 2207
  10. Cole, 2012, Water-soluble, deep-red fluorescent squaraine rotaxanes, Org. Biomol. Chem., 10, 5769, 10.1039/C2OB06783H · doi:10.1039/c2ob06783h
  11. Hsueh, 2010, Squaraine-based [2]rotaxanes that function as visibly active molecular switches, Chemistry, 16, 2997, 10.1002/chem.200903304 · doi:10.1002/chem.200903304
  12. Angeles-Boza, 2005, Photocytotoxicity of a new Rh2(II,II) complex: increase in cytotoxicity upon irradiation similar to that of PDT agent hematoporphyrin, Inorg. Chem., 44, 7262, 10.1021/ic0500715 · doi:10.1021/ic0500715
  13. To, 2013, Light-induced catalytic and cytotoxic properties of phosphorescent transition metal compounds with a d8 electronic configuration, Philos. Trans. A. Math. Phys. Eng. Sci., 371, 20120126, 10.1098/rsta.2012.0126 · doi:10.1098/rsta.2012.0126
  14. Liu, 2015, Evaluation of hypericin: effect of aggregation on targeting biodistribution, J. Pharm. Sci., 104, 215, 10.1002/jps.24230 · doi:10.1002/jps.24230
  15. Makdoumi, 2010, Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA), Graefes Arch. Clin. Exp. Ophthalmol., 248, 207, 10.1007/s00417-009-1231-2 · doi:10.1007/s00417-009-1231-2
  16. Ettinger, 2012, Preparation of cryoprecipitate from riboflavin and UV light-treated plasma, Transfus. Apher. Sci., 46, 153, 10.1016/j.transci.2012.01.004 · doi:10.1016/j.transci.2012.01.004
  17. Hamblin, 1996, Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells, Cancer Res., 56, 5205
  18. Hamblin, 1994, Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin, J. Photochem. Photobiol. B, 26, 45, 10.1016/1011-1344(94)85035-6 · doi:10.1016/1011-1344(94)85035-6
  19. Sobolev, 1992, Internalizable insulin-BSA-chlorin E6 conjugate is a more effective photosensitizer than chlorin E6 alone, Biochem. Int., 26, 445
  20. Kascakova, 2014, Somatostatin analogues for receptor targeted photodynamic therapy, PLoS One, 9, e104448, 10.1371/journal.pone.0104448 · doi:10.1371/journal.pone.0104448
  21. Li, 2013, A novel chlorin-PEG-folate conjugate with higher water solubility, lower cytotoxicity, better tumor targeting and photodynamic activity, J. Photochem. Photobiol. B, 127, 28, 10.1016/j.jphotobiol.2013.06.008 · doi:10.1016/j.jphotobiol.2013.06.008
  22. Brown, 2013, Advancements in using TiO2 bionanoconjugates for precision degradation of intracellular biological structures, J. Biomed. Nanotechnol., 9, 539, 10.1166/jbn.2013.1564 · doi:10.1166/jbn.2013.1564
  23. Mroz, 2011, Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma, Nanomedicine, 7, 965, 10.1016/j.nano.2011.04.007 · doi:10.1016/j.nano.2011.04.007
  24. Sette, 2013, Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO nanoparticles for targeting pancreatic ductal adenocarcinoma cells, J. Nanopart. Res., 15, 2111, 10.1007/s11051-013-2111-6 · doi:10.1007/s11051-013-2111-6
  25. Zhou, 2015, Multicolor imaging and the anticancer effect of a bifunctional silica nanosystem based on the complex of graphene quantum dots and hypocrellin A, Chem. Commun. (Camb.), 51, 421, 10.1039/C4CC06968D · doi:10.1039/c4cc06968d
  26. Ai, 2015, A core-shell-shell nanoplatform upconverting near-infrared light at 808 nm for luminescence imaging and photodynamic therapy of cancer, Sci. Rep., 5, 10785, 10.1038/srep10785 · DOI
  27. Dietze, 2003, Photochemical internalization enhances the cytotoxic effect of the protein toxin gelonin and transgene expression in sarcoma cells, Photochem. Photobiol., 78, 283, 10.1562/0031-8655(2003)078<0283:PIETCE>2.0.CO;2 · doi:10.1562/0031-8655(2003)078<0283:pietce>2.0.co;2
  28. Norum, 2009, Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery, Photochem. Photobiol., 85, 740, 10.1111/j.1751-1097.2008.00477.x · doi:10.1111/j.1751-1097.2008.00477.x
  29. Jerjes, 2011, Photodynamic therapy vs. photochemical internalization: the surgical margin, Head Neck Oncol., 3, 53, 10.1186/1758-3284-3-53 · doi:10.1186/1758-3284-3-53
  30. Mueller, 2010, From green to red–to more dead? Autofluorescent proteins as photosensitizers, J. Photochem. Photobiol. B, 98, 95, 10.1016/j.jphotobiol.2009.11.009 · doi:10.1016/j.jphotobiol.2009.11.009
  31. Serebrovskaya, 2011, Light-induced blockage of cell division with a chromatin-targeted phototoxic fluorescent protein, Biochem. J., 435, 65, 10.1042/BJ20101217 · doi:10.1042/bj20101217
  32. Jewhurst, 2014, Optogenetic control of apoptosis in targeted tissues of Xenopus laevis embryos, J. Cell Death, 7, 25, 10.4137/JCD.S18368 · doi:10.4137/jcd.s18368
  33. Ryumina, 2013, Flavoprotein miniSOG as a genetically encoded photosensitizer for cancer cells, Biochim. Biophys. Acta, 1830, 5059, 10.1016/j.bbagen.2013.07.015 · doi:10.1016/j.bbagen.2013.07.015
  34. Wang, 2015, Smart pH-responsive upconversion nanoparticles for enhanced tumor cellular internalization and near-infrared light-triggered photodynamic therapy, Chem. Commun. (Camb.), 51, 406, 10.1039/C4CC08178A · doi:10.1039/c4cc08178a
  35. Fu, 2014, Enzyme activated photodynamic therapy for methicillin-resistant Staphylococcus aureus infection both inv itro and in vivo, J. Photochem. Photobiol. B, 136, 72, 10.1016/j.jphotobiol.2014.04.016 · doi:10.1016/j.jphotobiol.2014.04.016
  36. Aggarwal, 2014, Photophysics of glycosylated derivatives of a chlorin, isobacteriochlorin and bacteriochlorin for photodynamic theragnostics: discovery of a two-photon-absorbing photosensitizer, Photochem. Photobiol., 90, 419, 10.1111/php.12179 · doi:10.1111/php.12179
  37. Kessel, 1986, Photosensitization with derivatives of haematoporphyrin, Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 49, 901, 10.1080/09553008514553131 · doi:10.1080/09553008514553131
  38. Moore, 2015, Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy, BJU Int., 116, 888, 10.1111/bju.12816 · doi:10.1111/bju.12816
  39. Stern, 1990, Photodynamic therapy with chloroaluminum sulfonated phthalocyanine in the rat window chamber, Am. J. Surg., 160, 360, 10.1016/S0002-9610(05)80543-4 · doi:10.1016/s0002-9610(05)80543-4
  40. Jajarm, 2015, A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus: a randomized clinical controlled trial, Lasers. Med. Sci., 30, 1475, 10.1007/s10103-014-1694-1 · doi:10.1007/s10103-014-1694-1
  41. Ali, 2011, Topical delivery and photodynamic evaluation of a multivesicular liposomal Rose Bengal, Lasers Med. Sci., 26, 267, 10.1007/s10103-010-0859-9 · doi:10.1007/s10103-010-0859-9
  42. Goff, 1994, Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model, Br. J. Cancer, 70, 474, 10.1038/bjc.1994.330 · doi:10.1038/bjc.1994.330
  43. El-Akra, 2006, Synthesis of estradiol-pheophorbide a conjugates: evidence of nuclear targeting, DNA damage and improved photodynamic activity in human breast cancer and vascular endothelial cells, Photochem. Photobiol. Sci., 5, 996, 10.1039/b606117f · doi:10.1039/b606117f

Cited by

See all 2,033

Metadata

Authors
Abrahamse, H., & Hamblin, M. R.
Venue
Biochemical Journal
Published
2016-02-09
Volume
473
Issue
4
Pages
347-364
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2278726896
Cited by
2,033
References
120
FWCI
120.76
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.